Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention-Reference-Cited by-同舟云学术

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Published:2018-09-24 Issue:3 Volume:10 Page:149-152
ISSN:2008-5117
Container-title:Journal of Cardiovascular and Thoracic Research
language:en
Short-container-title:J Cardiovasc Thorac Res

Author:

Firouzi Ata,Kazem Moussavi Ali,Mohebbi Ahmad,Alemzadeh-Ansari Mohammad Javad,Kiani Reza,Sanati Hamid Reza,Mohebbi Bahram,Shakerian Farshad,Zahedmehr Ali,Ansari-Ramandi Mohammad Mostafa,Oni Heris Saeed,Ghaleshi Bahar,Ghorbani Fatemeh

Publisher

Maad Rayan Publishing Company

Subject

Cardiology and Cardiovascular Medicine

Link

http://jcvtr.tbzmed.ac.ir/pdf/jcvtr-10-149.pdf

Reference23 articles.

1. Growing epidemic of coronary heart disease in low-and middle-income countries;Gaziano T;Curr Probl Cardiol,2010

2. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

3. Dose Response Between Physical Activity and Risk of Coronary Heart Disease

4. Forecasting the Future of Cardiovascular Disease in the United States

5. Prevalence of coronary heart disease--United States, 2006-2010;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Prophylactic High-Dose Statin Therapy to Reduce Contrast-Induced Acute Kidney Injury in Adults Undergoing Acute Coronary Angiography;Dimensions of Critical Care Nursing;2023-09

2. Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention;Disease Markers;2022-06-28

3. Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin;Journal of Family Medicine and Primary Care;2022

4. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis;Clinics;2021

5. Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous Coronary Intervention Rate and the Risk Factors in Patients with Coronary Heart Disease;Current Drug Metabolism;2020-12-15